UBS Group’s SQZ Biotechnologies Company SQZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,410
| Closed | -$381 | – | 9046 |
|
|
2023
Q2 | $381 | Sell |
1,410
-1,214
| -46% | -$328 | ﹤0.01% | 7180 |
|
|
2023
Q1 | $1.47K | Buy |
+2,624
| New | +$1.47K | ﹤0.01% | 7632 |
|
|
2022
Q4 | – | Sell |
-3,337
| Closed | -$8K | – | 10113 |
|
|
2022
Q3 | $8K | Buy |
3,337
+344
| +11% | +$825 | ﹤0.01% | 7695 |
|
|
2022
Q2 | $10K | Buy |
+2,993
| New | +$10K | ﹤0.01% | 7024 |
|
|
2022
Q1 | – | Sell |
-14,277
| Closed | -$128K | – | 9928 |
|
|
2021
Q4 | $128K | Buy |
14,277
+7,277
| +104% | +$65.2K | ﹤0.01% | 5019 |
|
|
2021
Q3 | $101K | Buy |
7,000
+3,233
| +86% | +$46.6K | ﹤0.01% | 4753 |
|
|
2021
Q2 | $54K | Buy |
3,767
+2,314
| +159% | +$33.2K | ﹤0.01% | 5307 |
|
|
2021
Q1 | $20K | Buy |
1,453
+523
| +56% | +$7.2K | ﹤0.01% | 6387 |
|
|
2020
Q4 | $27K | Buy |
+930
| New | +$27K | ﹤0.01% | 5723 |
|